Skip to main content
Caplight Logo









Perelel

Perelel

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://perelelhealth.com

Last Round

Series A

Extension

Nov 20, 2025

Est. Valuation

$145M

Total Funding Raised

$37.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Perelel operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Series A Extension round in November 2025.

Perelel is a femtech company that provides doctor-formulated vitamin supplements for women's reproductive and hormonal health.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Subscription Commerce, Sports & Fitness, E-commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Perelel Comparables

Compare Perelel with similar companies based on industry and business-model similarity.

Perelel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Needed
94%
Ritual
86%
Binto
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Perelel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 20, 2025
Series AFeb 1, 2024
SeedJul 19, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Alex Taylor

Co-Founder & Chief Brand and Creative Officer

Founding Team

Victoria Thain Gioia

Founder & Co-CEO

Founding Team

Lauren McMahon

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Perelel Investors

Notable investors and investment history

Perelel investors
InvestorRounds
Selva VenturesSeries A Extension, Series A
Prelude Growth PartnersSeries A Extension
Willow Growth PartnersSeries A Extension, Seed, Series A
Unilever VenturesSeries A Extension, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 129% MoM, reaching 629.6K.

  • Jul 18, 2026

    Grew 19% QoQ, from 43 to 51 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withOct 1, 2026

    Perelel, Inc. partners with Coterie, Inc. on a limited-edition bundle, with more than 75 kits ready to ship the same day as launch and the collaboration selling out within 72 hours.

  • has_revenueSep 29, 2026

    Perelel, Inc. crossed a $100M annual revenue run rate as of Aug '24.

  • launchesSep 12, 2026

    Perelel, Inc. launches its clinically studied Triple-Support Protein, which provides plant-based protein, creatine, and prebiotic fiber, at more than 65 Bluestone Lane cafés across the United States on Sep 10th '26.

  • partners_withSep 10, 2026

    In California on Sep 10th '26, Perelel, Inc. and Bluestone Lane launch a year-long national partnership bringing clinically studied Triple-Support Protein to more than 65 cafés, beginning with a limited-time Pumpkin Chai offering.

Book a demo to see all news

For institutional investors. Book with your work email.

Perelel Filings

Explore SEC and related filing metadata, where available.

Perelel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Perelel's valuation, stock price, and market status.

Is Perelel a public or private company?

Perelel is a private company.

What is the current stock price of Perelel?

Perelel is a private company, so its shares have no public market price. Caplight tracks Perelel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Perelel worth (valuation)?

Perelel's valuation is estimated at $145.0M based on funding round data.

Can I buy Perelel stock?

Perelel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Perelel's last funding round?

Perelel's most recent funding round was Series A Extension on November 20, 2025.

Who are the main investors in Perelel?

Key investors in Perelel include Selva Ventures, Prelude Growth Partners, Willow Growth Partners, Unilever Ventures.

Will Perelel IPO soon?

No public IPO plans have been announced for Perelel.

How can I track Perelel secondary market activity?

Caplight tracks bids, offers, and trades in Perelel's shares on secondary markets.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range47
Year Founded2020
Last FundingNov 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?